Stock MLTX MOONLAKE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq
Other stock markets
 01:30:00 15/06/2024 am IST 		5-day change 1st Jan Change
41.41 USD -3.04% Intraday chart for MoonLake Immunotherapeutics -0.62% -31.43%
10/06 MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from Both FDA and EMA on Path for the Phase 3 Program for the Nanobody Sonelokimab in Psoriatic Arthritis CI
07/05 MoonLake Immunotherapeutics Q1 Net Loss Widens MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
MOONLAKE IMMUNOTHERAPEUTICS
Bio Therapeutic Drugs
-3.04%-0.62%-31.43%+54.34% - 2.6B
Neutral
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. MLTX Stock
  4. Charts MoonLake Immunotherapeutics
  5. Comparison Chart